Chimeric Antigen Receptor T (CAR T) cells are a form of immunotherapy where a patient's T cells are genetically engineered to express receptors that specifically target cancer cells. This cutting-edge treatment has shown promise in various hematologic malignancies and is now being explored in solid tumors, including gynecologic cancers.
